Entities / Company
Bausch Health.
multinational specialty drugs company based in Laval, Quebec, Canada
- Reports this week
- 6
- Active events
- 3
- Connections
- 58
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
-
Johnson & Johnson, Carl Zeiss, and Bausch Health are major players in the vision care market, supported by supportive government initiatives.Some support2 reports4 developments inside
-
Bausch Health authorized a $50 million share repurchase program on October 29, 2026.Some support1 report
-
Bausch Health may repurchase shares on the New York Stock Exchange.Some support4 reports
Earlier this month
One to three months ago
-
Analyst upgrades and downgrades are affecting the stock prices of Bausch Health, Aflac, and Capri.Some support1 report
-
Bausch Health is expanding its portfolio into several markets, including Slovakia, Bulgaria, Czech Republic, and Mexico.Some support1 report
-
Bausch Health made technology available in Australia in January 2026.Some support4 reports
-
Bausch Health made its technology available in Australia on January 1, 2026.Some support1 report
-
Renaissance Technologies raised its position and increased holdings in Bausch Health stock, while also dropping its target price.Some support2 reports
Gone quiet
No new reports in 90+ days-
Bausch Health reports Vision Care revenue growth and anticipates key regulatory milestones for Elios.Some support1 report
-
Bausch + Lomb, a subsidiary of Bausch Health, announced the resignation of board members Brett M. Icahn and Gary Hu.Some support2 reports
-
Michael Goettler, formerly of Viatris, was appointed to the Board of Directors of Bausch Health.Some support4 reports
-
Bausch Health is a major beneficiary of Trump tariffs, and Steven D. Miller resigned from the company’s board.Some support1 report
-
Bausch Health started using LinkedIn for company connection in July 2025.Speculative1 report
-
On July 11, 2025, Hologic was noted as Gen-Probe Incorporated. Companies including Bausch Health, Meridian Bioscience, and others are advancing testing technologies and treatment options.Some support1 report
-
Steven Lee was appointed Chief Accounting Officer of a company (implied Bausch Health) on July 11, 2025, where he had previously held senior roles.Some support1 report
-
Pfizer, Merck, Bausch Health, Viatris, and Santen Pharmaceutical are listed as key companies in glaucoma trials.Some support1 report
-
Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.Some support3 reports1 development inside
-
Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.Some support3 reports
-
Bausch Health extended a tender offer for shares of Durect.Some support1 report1 development inside
-
Acquisition between Durect and Bausch Health advances liver disease treatment.Well supported3 reports
-
Milestone payments tied to Bausch Health's sales in the US were announced on August 13, 2025.Some support1 report
-
Brett and Steven D. Miller resigned from the Bausch Health Board of Directors in August 2025.Some support1 report
-
Brett Icahn resigned from Bausch Health's board and built an economic interest in the company's shares.Some support1 report
-
Solta Medical became part of Bausch Health on September 5, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Bausch Health
Events traced to Bausch Health, step by step, newest firstExplainers that pass through Bausch Health
Bausch Health is a step on the way to someone elseAround Bausch Health this week
News at the entities that move Bausch Health most-
SEC StructuralDemocrats aim to retake Congress while the Federal Reserve pins rates and crypto problems strain SEC oversight.Moves Bausch Health
-
Renaissance Technologies TransactionalBlackRock, OMERS, Renaissance Technologies, and Bank of America increased their stakes in Paramount Gold Nevada Corp. stock on November 1, 2026.Moves Bausch Health
-
board of directors StructuralPower Grid Corporation of India Ltd approved a dividend and divestment and reported financial results in Mumbai.Moves Bausch Health
-
Royal Bank of Canada TransactionalRoyal Bank of Canada dropped its price target for Fiverr International from $16.00 to $9.00, with MarketBeat aggregating the rating.Moves Bausch Health
-
Jefferies Financial Group TransactionalExxonMobil is facing institutional investment disclosure requirements as Jefferies and HSBC provide updated rating and price targets.Moves Bausch Health
-
Slovakia OperationalTachyum filed for bankruptcy in Bratislava, with its IP held by a Cayman Islands company and development managed by a Slovak subsidiary.Moves Bausch Health
Connections
The 20 strongest of 58, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Salix Structural
Salix is formally defined as a revenue segment within Bausch Health's business structure.
-
Salix Pharmaceuticals Structural
Bausch Health acquired Salix Pharmaceuticals, which operates as a subsidiary business unit.
-
Michael Goettler Structural
Michael Goettler served on Bausch Health's Board of Directors from July 2025 until his resignation in July 2026.
-
Brent Saunders Structural
Brent Saunders served as the Chairman and CEO of Bausch Health.
-
Durect (United States) Transactional
Bausch Health is actively acquiring Durect through a tender offer and subsequent acquisition.
-
Royal Bank of Canada Transactional
RBC actively monitors Bausch Health's performance and has increased its financial stake in the company.
-
VISION CARE Structural
Vision Care operates as a business unit contributing to Bausch Health's overall revenue growth.
-
SEC Structural
Bausch Health is subject to formal regulatory oversight by the SEC, evidenced by required insider sale disclosures.
Show all 20 connections
-
Renaissance Technologies Transactional
Renaissance Technologies increased its investment holdings in Bausch Health stock.
-
board of directors Structural
Bausch Health relies on its board of directors for governance and oversight, including the appointment of key executives.
-
John Paulson Transactional
John Paulson or his associates acquired shares in Bausch Health through insider transactions.
-
Czech Republic Operational
Bausch Health is actively pursuing market presence and expanding its business portfolio within the Czech Republic.
-
Kazakhstan Shared context
Bausch Health is forecasted to establish operational presence in Kazakhstan starting in October 2026.
-
Jefferies Financial Group Transactional
Jefferies upgraded Bausch Health to a hold rating.
-
Elios Operational
Bausch Health is actively involved in the regulatory development and milestones of Elios.
-
Carl Icahn Transactional
The relationship involved Carl Icahn building economic interest in Bausch Health shares and subsequently terminating an agreement.
-
Ohio Shared context
Bausch Health is observed within the economic context of Ohio.
-
Slovakia Operational
Bausch Health is actively expanding its business portfolio into the Slovakian market.
-
Bulgaria Shared context
Bausch Health is expanding its business portfolio into the Bulgarian market.
-
New York Stock Exchange Transactional
Bausch Health is forecasted to conduct a share repurchase utilizing the New York Stock Exchange platform.
History
Events by the month they beganOctober 2026
4 events- Bausch Health authorized a $50 million share repurchase program on October 29, 2026.
- Bausch Health may repurchase shares on the New York Stock Exchange.
- Bioscience Association Manitoba works to strengthen the province's bioscience ecosystem, announcing several new board and executive appointments.
- Bausch Health and Palisade Bio, Inc. are being compared for potential investment.
September 2026
4 events- Analyst upgrades and downgrades are affecting the stock prices of Bausch Health, Aflac, and Capri.
- Bausch Health is expanding its portfolio into several markets, including Slovakia, Bulgaria, Czech Republic, and Mexico.
- Bausch Health made technology available in Australia in January 2026.
- Bausch Health made its technology available in Australia on January 1, 2026.
August 2026
1 eventShow 2 earlier months
July 2026
1 eventJune 2026
16 events- Johnson & Johnson, Carl Zeiss, and Bausch Health are major players in the vision care market, supported by supportive government initiatives.
- Bausch + Lomb, a subsidiary of Bausch Health, announced the resignation of board members Brett M. Icahn and Gary Hu.
- Michael Goettler, formerly of Viatris, was appointed to the Board of Directors of Bausch Health.
- Bausch Health is a major beneficiary of Trump tariffs, and Steven D. Miller resigned from the company’s board.
- Bausch Health started using LinkedIn for company connection in July 2025.
- On July 11, 2025, Hologic was noted as Gen-Probe Incorporated. Companies including Bausch Health, Meridian Bioscience, and others are advancing testing technologies and treatment options.
- Steven Lee was appointed Chief Accounting Officer of a company (implied Bausch Health) on July 11, 2025, where he had previously held senior roles.
- Pfizer, Merck, Bausch Health, Viatris, and Santen Pharmaceutical are listed as key companies in glaucoma trials.
- Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.
- Bausch Health reported that international revenues grew due to growth in Canada, driven by its segment Salix.
- Bausch Health extended a tender offer for shares of Durect.
- Acquisition between Durect and Bausch Health advances liver disease treatment.
- Milestone payments tied to Bausch Health's sales in the US were announced on August 13, 2025.
- Brett and Steven D. Miller resigned from the Bausch Health Board of Directors in August 2025.
- Brett Icahn resigned from Bausch Health's board and built an economic interest in the company's shares.
- Solta Medical became part of Bausch Health on September 5, 2025.